Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 191 to 200

SITAGLIPTIN GH sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
SITAGLIPTIN GH sitagliptin (as hydrochloride monohydrate) 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TADALAFIL GENERICHEALTH tadalafil10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
GOANNA Oil Liniment bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TERRYWHITE CHEMMART ESOMEPRAZOLE REFLUX RELIEF esomeprazole (as magnesium) 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TERRYWHITE CHEMMART PARACETAMOL OSTEO 665 paracetamol 665 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRA-LAX topiramate 100 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRA-LAX topiramate 25 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 100 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TOPIRAMATE-LUPIN topiramate 100 mg tablet blister Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 16
Page 17
Page 18
Page 19
Current page 20
Page 21
Page 22
Page 23
Page 24
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.